Novartis, UCSF researchers urge FDA to clean up its messy adverse events database
A team of researchers from Novartis, Oracle Health Sciences and the University of California, San Francisco say the FDA’s adverse drug reaction database could be …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
